Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Larimar Therapeutics (LRMR) Receivables Refunds (2016 - 2020)

Larimar Therapeutics (LRMR) has disclosed Receivables Refunds for 7 consecutive years, with $235000.0 as the latest value for Q3 2019.

  • For the quarter ending Q3 2019, Receivables Refunds fell 81.12% year-over-year to $235000.0, compared with a TTM value of $235000.0 through Sep 2019, down 81.12%, and an annual FY2018 reading of $1.5 million, up 62.37% over the prior year.
  • Receivables Refunds was $235000.0 for Q3 2019 at Larimar Therapeutics, down from $1.5 million in the prior quarter.
  • Across five years, Receivables Refunds topped out at $1.5 million in Q1 2019 and bottomed at $235000.0 in Q3 2019.
  • Average Receivables Refunds over 5 years is $893684.2, with a median of $932000.0 recorded in 2018.
  • The sharpest move saw Receivables Refunds soared 320.06% in 2016, then tumbled 81.12% in 2019.
  • Year by year, Receivables Refunds stood at $1.3 million in 2015, then plummeted by 73.77% to $347000.0 in 2016, then surged by 172.62% to $946000.0 in 2017, then skyrocketed by 62.37% to $1.5 million in 2018, then tumbled by 84.7% to $235000.0 in 2019.
  • Business Quant data shows Receivables Refunds for LRMR at $235000.0 in Q3 2019, $1.5 million in Q2 2019, and $1.5 million in Q1 2019.